drugset / Trial / NCT01893879
Placebo-Controlled Therapeutic Trial for the Prevention of Lymphedema
RandomizedParallel-groupDouble-blindPrevention
Summary
This randomized clinical trial studies an investigational drug in preventing lymphedema in patients at high risk after undergoing axillary lymph node dissection. The study drug may prevent lymphedema in patients undergoing axillary lymph node dissection.
Timeline
- Start
- 2014-04
- Primary completion
- 2015-04
- Completion
- 2015-04
Outcome
Outcome not reported
Stopped (Enrollment): “insufficient enrollment”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | (RS)2-(3-benzoylphenyl)-propionic acid | Unknown | — | Oral |